ADC Therapeutics SA (ADCT)
4.01
+0.48
(+13.60%)
USD |
NYSE |
Dec 10, 16:00
3.99
-0.02
(-0.50%)
Pre-Market: 07:46
ADC Therapeutics Shareholders Equity (Quarterly): -238.18M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alcon AG | 22.09B |
| BeOne Medicines Ltd. | 4.129B |
| AC Immune SA | 78.48M |
| CRISPR Therapeutics AG | 1.916B |
| Addex Therapeutics Ltd. | 7.480M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 289.76M |
| Total Liabilities (Quarterly) | 527.94M |
| Debt to Equity Ratio | -1.920 |
| Current Ratio | 4.628 |
| Net Debt Paydown Yield | -14.79% |